Dr. Jared Feldman is an Associate at Autobahn Labs. Prior to Autobahn, Jared worked on the Business Development team at Vir Biotechnology, evaluating clinical-stage assets and platform technologies for infectious diseases and immunology indications.
Jared received a BA in Biochemistry from Bowdoin College and a PhD from Harvard’s Virology Program where he studied humoral immune responses to preemergent viral pathogens. Simultaneously, he worked as a Business Development Fellow for the Harvard University Office of Technology Development (OTD). Before graduate school, Jared was an antibody engineer at Adimab, supporting therapeutic monoclonal antibody discovery campaigns.
